IRIS
FACCHINETTI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 630
EU - Europa 462
AS - Asia 240
SA - Sud America 3
AF - Africa 1
Totale 1.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 622
SE - Svezia 159
IE - Irlanda 132
CN - Cina 110
SG - Singapore 103
IT - Italia 84
DE - Germania 31
AT - Austria 17
IN - India 10
CA - Canada 8
GB - Regno Unito 8
TR - Turchia 8
FR - Francia 7
BE - Belgio 5
FI - Finlandia 5
AL - Albania 3
BR - Brasile 3
IL - Israele 2
JP - Giappone 2
KH - Cambogia 2
RU - Federazione Russa 2
UA - Ucraina 2
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
HK - Hong Kong 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.336
Salva come PNG Salva come JPEG
Città #
Chandler 195
Dublin 129
Singapore 73
Ashburn 49
Shanghai 48
New York 44
Ann Arbor 35
Boardman 30
Princeton 23
Bremen 20
Vienna 17
Dearborn 14
Parma 13
Des Moines 12
Wilmington 11
Beijing 8
Nanjing 8
Pune 7
Santa Clara 6
Brussels 5
Changsha 5
Dallas 5
Helsinki 5
Izmir 5
Milan 5
Bologna 4
Busseto 4
Kunming 4
Nanchang 4
Pavia 4
Fremont 3
Grafing 3
Guangzhou 3
Hebei 3
Jinan 3
Marseille 3
Nanning 3
Naples 3
Redwood City 3
Shenyang 3
Tirana 3
Washington 3
Woodbridge 3
Candiac 2
Fairfield 2
Foligno 2
Frankfurt am Main 2
Genoa 2
Houston 2
Istanbul 2
Jiaxing 2
Minerbio 2
Newark 2
Norwalk 2
Reggio Emilia 2
Rome 2
Toronto 2
Trento 2
West Jordan 2
Abidjan 1
Andover 1
Bangalore 1
Bordeaux 1
Borås 1
Bucharest 1
Cambridge 1
Dolianova 1
Florence 1
Fortaleza 1
Francisco Morato 1
Hangzhou 1
Hefei 1
Kingston 1
Kocaeli 1
Lanzhou 1
Little Attock 1
London 1
Los Angeles 1
Luxembourg 1
Macomer 1
Munich 1
Ningbo 1
Ottawa 1
Pavullo Nel Frignano 1
Redmond 1
Rockville 1
Saint Petersburg 1
San Jose 1
San Mateo 1
Santa Coloma de Gramenet 1
São Gabriel do Oeste 1
Tappahannock 1
Vientiane 1
Wuhan 1
Xingtai 1
Zurich 1
Totale 900
Salva come PNG Salva come JPEG
Nome #
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 117
Widespread Nivolumab-induced Enteropathy in a Long Responder Non–Small-cell Lung Cancer Patient 98
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 79
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors 73
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 71
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib 69
CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients 67
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition 63
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 62
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: A systematic review and meta-analysis 62
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination 61
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors 54
Osimertinib in CNS-progressive EGFR-mutant lung cancer: do we need to detect T790M? 53
Moving immune checkpoint blockade in thoracic tumors beyond NSCLC 52
Exploring the role of respiratory microbiome in lung cancer: A systematic review 51
Cystic brain metastases and RET fusion in lung cancer 49
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy 49
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib 47
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: A systematic review and meta-analysis 46
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status 42
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib 39
Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer 36
Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary? 25
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 21
Totale 1.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 12 12 11 6 4 5 0 3
2020/202164 1 0 4 8 7 5 1 8 13 6 9 2
2021/2022150 2 2 0 29 2 3 27 7 9 6 7 56
2022/2023619 81 76 38 56 45 77 23 31 164 6 21 1
2023/2024229 11 19 3 2 17 80 18 17 12 10 10 30
2024/2025168 6 30 35 47 50 0 0 0 0 0 0 0
Totale 1.386